Regulatory physique specialists clear Bharat Biotech’s nasal COVID vaccine for Part 1 trials
Tribune News Service New Delhi, January 19 The subject expert committee of the national regulatory authority on Tuesday night recommended grant of phase one clinical trial for India’s first intra-nasal COVID vaccine being developed by…
Read More